Jonathan Akehurst
Corporate Officer/Principal at Clearstream Technologies Group Ltd.
Jonathan Akehurst active positions
| Companies | Position | Start | End |
|---|---|---|---|
Clearstream Technologies Group Ltd.
 Clearstream Technologies Group Ltd. Medical SpecialtiesHealth Technology Clearstream Technologies Group develops and manufactures medical devices. It develops, manufactures and markets medical devices used by interventional cardiologists, radiologists, and vascular surgeons in angioplasty procedures. The company was founded in 1996 and is headquartered in Enniscorthy, Ireland. | Corporate Officer/Principal | 01/02/2009 | - |
Career history of Jonathan Akehurst
Former positions of Jonathan Akehurst
| Companies | Position | Start | End |
|---|---|---|---|
Cappella, Inc.
 Cappella, Inc. Pharmaceuticals: MajorHealth Technology Cappella, Inc. operates as a medical device company, which develops novel solutions for the treatment of complex coronary artery disease (CAD) and specifically bifurcation vascular disease. The company was founded by Antonio Columbo and Ascher Shmulewitz in 2004 and is headquartered in Boston, MA. | Chief Executive Officer | - | - |
| President | - | - |
Statistics
International
| United Kingdom | 2 |
| Ireland | 2 |
Operational
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
| President | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Clearstream Technologies Group Ltd.
Clearstream Technologies Group Ltd. Medical SpecialtiesHealth Technology Clearstream Technologies Group develops and manufactures medical devices. It develops, manufactures and markets medical devices used by interventional cardiologists, radiologists, and vascular surgeons in angioplasty procedures. The company was founded in 1996 and is headquartered in Enniscorthy, Ireland. | Health Technology |
Cappella, Inc.
Cappella, Inc. Pharmaceuticals: MajorHealth Technology Cappella, Inc. operates as a medical device company, which develops novel solutions for the treatment of complex coronary artery disease (CAD) and specifically bifurcation vascular disease. The company was founded by Antonio Columbo and Ascher Shmulewitz in 2004 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Jonathan Akehurst
- Experience
